Carasent Q2 2023: Initial comment

Research Note



Redeye comments on Carasent's Q2 2023 report, which showed small improvements compared to the previous quarter. Sales were slightly higher than our estimate, although margins continued to be subpar. However, we believe the margins will strengthen over time, thanks to the cost-savings program and increased sales volumes. The next catalyst will clearly be the Capital Markets Day during the fall, where we could receive more guidance on sales, margins, capital structure and long-term vision.


Mark Siöstedt

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.